Call for Papers
Call for Papers
Abstract submission period: 10:00am, October 15 (Fri.) – 12:00pm, December 20 (Mon.) (Japan Standard Time, UTC+9)
Notification of acceptance or rejection: the mid of February 2022 (tentative)
Type of Presentation
The author can indicate preference on the type of presentation. However, the final decision of presentation style is made by the Program Committee, and your understanding and corporation are highly appreciated.
- Oral
- Poster
- Either will be fine
Abstract submission guidelines
- All applicants are required to create a user account first. After creating the account, you can submit your abstract for this annual meeting with the account.
- Once the submission is completed, a confirmation e-mail will be sent automatically. If you do not receive the confirmation e-mail within 24 hours after submission, please contact the Congress Secretariat (E-mail:jspn118-p@jtbcom.co.jp).
- Abstract number will be generated automatically when an abstract is submitted.
- For changes, withdrawal or additional submission, please log in to the system using your ID and password from "Abstract Submission" button at the bottom of this page.
Submission Guideline
Title: up to 100 characters in single byte
Body of abstract: up to 300 words in single byte
Co-authors: up to 30 persons
Affiliations: up to 10 affiliations
Categories
Please choose the category for your paper.
*up to 3 categories can be registered. *you are required to choose at least 1 category.
1 | Schizophrenia and related disorders |
---|---|
2 | Mood disorders |
3 | Neurotic disorders and related disorders |
4 | Personality disorders |
5 | Epilepsy |
6 | Dementia |
7 | Behavioural syndromes associated with physiological disturbances and physical factors |
8 | Organic and symptomatic mental disorders |
9 | Substance abuse and dependence |
10 | Mental disorders in childhood and adolescence |
11 | Sleep disorders |
12 | Mental retardation |
13 | Mental disorders in old age |
14 | Forensic psychiatry |
15 | Mental health and welfare |
16 | Medical education |
17 | Psychopathology |
18 | Neuropsychology |
19 | Neurophysiology |
20 | Psychopharmacology |
21 | Neurochemistry |
---|---|
22 | Neuropathology |
23 | Genetics and molecular genetics |
24 | Epidemiology |
25 | Community mental health services |
26 | Emergency psychiatry |
27 | Consultation-liaison psychiatry |
28 | Psychiatric diagnosis |
29 | Symptomatology |
30 | Pharmacotherapy |
31 | Psychotherapy |
32 | Psychosocial therapy/psychoeducation |
33 | ECT/TMS/neuromodulation |
34 | Laboratory tests/biomarkers |
35 | Neuroimaging |
36 | Animal model/basic research |
37 | Suicide prevention |
38 | Occupational mental health |
39 | Social psychiatry |
40 | COVID-19 |
41 | AI |
42 | Others |
Personal Information Protection
“Names” and “contact addresses” provided to us at registration for the meeting shall be used for the purpose of contact from the secretariat, notification of acceptance or rejection, and any information related to the presentation. In addition, the “presenters' names,” “affiliation,” “title” and “abstract text” shall be used for publication in the program/proceedings and on the website, but not for other purposes. The registration process for applications has been commissioned to c/o JTB Communication Design, Inc. in order to facilitate management operations.
Inquiry
The 118th Annual Meeting of the Japanese Society of Psychiatry and Neurology
Congress Secretariat
c/o JTB Communication Design, Inc.
E-mail: jspn118-p@jtbcom.co.jp